BIANCHI, MARZIA
 Distribuzione geografica
Continente #
NA - Nord America 11.786
EU - Europa 6.472
AS - Asia 3.938
SA - Sud America 356
Continente sconosciuto - Info sul continente non disponibili 173
AF - Africa 65
OC - Oceania 27
Totale 22.817
Nazione #
US - Stati Uniti d'America 11.565
GB - Regno Unito 2.414
CN - Cina 1.880
SG - Singapore 1.075
IT - Italia 888
UA - Ucraina 826
SE - Svezia 486
RU - Federazione Russa 434
DE - Germania 405
FI - Finlandia 399
TR - Turchia 340
BR - Brasile 282
VN - Vietnam 197
IE - Irlanda 187
FR - Francia 177
CA - Canada 134
IN - India 106
JP - Giappone 64
HK - Hong Kong 50
MX - Messico 50
KR - Corea 48
PL - Polonia 47
BE - Belgio 45
PK - Pakistan 31
NL - Olanda 30
BD - Bangladesh 28
AR - Argentina 27
ES - Italia 27
ZA - Sudafrica 20
CZ - Repubblica Ceca 19
AU - Australia 18
IQ - Iraq 18
LT - Lituania 16
AT - Austria 15
ID - Indonesia 11
MA - Marocco 11
RO - Romania 11
VE - Venezuela 11
IR - Iran 10
AE - Emirati Arabi Uniti 9
CO - Colombia 9
EG - Egitto 9
NZ - Nuova Zelanda 9
SA - Arabia Saudita 9
TG - Togo 9
CR - Costa Rica 8
EC - Ecuador 8
IL - Israele 8
JM - Giamaica 8
JO - Giordania 7
PH - Filippine 7
PT - Portogallo 7
TT - Trinidad e Tobago 7
CL - Cile 6
EU - Europa 5
HU - Ungheria 5
KG - Kirghizistan 5
PY - Paraguay 5
SK - Slovacchia (Repubblica Slovacca) 5
BB - Barbados 4
BG - Bulgaria 4
DK - Danimarca 4
NP - Nepal 4
TN - Tunisia 4
TW - Taiwan 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
BH - Bahrain 3
CH - Svizzera 3
DZ - Algeria 3
GT - Guatemala 3
KE - Kenya 3
KZ - Kazakistan 3
LV - Lettonia 3
MY - Malesia 3
NO - Norvegia 3
PE - Perù 3
QA - Qatar 3
RS - Serbia 3
UY - Uruguay 3
BO - Bolivia 2
GR - Grecia 2
HN - Honduras 2
IM - Isola di Man 2
LA - Repubblica Popolare Democratica del Laos 2
PA - Panama 2
SV - El Salvador 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
LU - Lussemburgo 1
MK - Macedonia 1
MM - Myanmar 1
Totale 22.645
Città #
Southend 2.147
Ashburn 1.404
Woodbridge 1.177
Fairfield 1.141
Houston 752
Ann Arbor 736
Jacksonville 662
Singapore 552
San Jose 541
Chandler 508
Seattle 489
Cambridge 455
Wilmington 394
Nanjing 326
Beijing 304
Dallas 296
Izmir 247
Boardman 224
Helsinki 192
Dublin 185
Council Bluffs 169
Los Angeles 149
Urbino 146
Nanchang 130
New York 122
Princeton 99
Lauterbourg 98
Munich 98
San Mateo 94
Santa Clara 89
Düsseldorf 86
Shenyang 82
Hebei 65
Changsha 64
Tianjin 54
Ho Chi Minh City 52
Bremen 50
Jiaxing 50
Istanbul 49
Hong Kong 47
Buffalo 46
Chicago 45
Brussels 43
San Diego 41
São Paulo 41
Frankfurt am Main 40
Shanghai 40
Tokyo 40
Montreal 38
Moscow 37
Jinan 36
San Francisco 36
London 35
Hanoi 34
Toronto 34
Kunming 32
Mülheim 31
Denver 30
Warsaw 29
Chennai 28
Poplar 28
Atlanta 27
Hangzhou 27
Zhengzhou 27
Guangzhou 26
Orem 26
Phoenix 26
Seongnam 26
Velikiy Novgorod 26
Ottawa 25
Turku 25
Dong Ket 24
Rome 21
The Dalles 21
Brooklyn 20
Ningbo 20
Stockholm 20
Bologna 18
Des Moines 18
North Bergen 18
Mexico City 16
Venice 16
Rawalpindi 15
Brno 14
Macerata 14
Mumbai 14
Norwalk 14
Pesaro 14
Seoul 14
Manchester 13
Milan 13
Redwood City 13
Agugliano 12
Ascoli Piceno 12
Boston 12
Kraków 12
Lanzhou 12
Las Vegas 12
Ancona 11
Changchun 11
Totale 15.994
Nome #
Yin Yang 1 intronic binding sequences and splicing elicit intron-mediated enhancement of ubiquitin C gene expression 471
Stochastic modelling of PTEN regulation in brain tumors: a model for Glioblastoma Multiforme 453
Covalent functionalization of SWCNTs with ODNs targeting NF-kB: toward the construction of cell-penetrating decoy molecoles. 398
Molecular Dissection of the Human Ubiquitin C Promoter Reveals Heat Shock Element Architectures with Activating and Repressive Functions 380
Ubiquitin C gene: Structure, function, and transcriptional regulation 356
Dynamic transcription of ubiquitin genes under basal and stressful conditions and new insights into the multiple UBC transcript variants 351
Ubiquitin over-expression promotes E6AP autodegradation and reactivation of the p53/MDM2 pathway in HeLa cells 342
Label-free quantification of activated NF-kB in biological samples by atomic force microscopy 330
Nano-Mechanical Characterization of Ataxia Telangiectasia Cells Treated with Dexamethasone 328
A negative feedback mechanism links UBC gene expression to ubiquitin levels by affecting RNA splicing rather than transcription. 307
A potent enhancer element in the 5'-UTR intron is crucial for transcriptionalregulation of the human ubiquitin C gene 303
A recombinant human 'mini'-hexokinase is catalytically active and regulated by hexose 6-phosphates 300
Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response 300
Transcription factor decoy oligonucleotides modified with locked nucleic acids: an in vitro study to reconcile biostability with binding affinity 295
Forward subtractive libraries containing genes transactivated by dexamethasone in ataxia-telangiectasia lymphoblastoid cells 290
Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs 290
Dehydroascorbic acid irreversibly inhibits hexokinase activity. 285
A NONLINEAR THREE-COMPARTMENT MODEL FOR THE ADMINISTRATION OF 2’, 3’- DIDEOXYCYTIDINE BY USING RED BLOOD CELLS AS BIOREACTORS 280
Dexamethasone partially rescues ataxia telangiectasia-mutated (ATM) deficiency in ataxia telangiectasia by promoting a shortened protein variant retaining kinase activity. 278
Expression, purification, and characterization of a recombinant erythroid-specific hexokinase isozyme 272
De-ubiquitylation is the most critical step in the ubiquitin mediated homeostatic control of the NF-kB/IKK basal activity 272
Locked nucleic acids (LNA): versatile tools for designing oligonucleotide decoys with high stability and affinity 269
Oxidized ultrashort nanotubes as carbon scaffolds for the construction of cell-penetrating NF-kappaB decoy molecules 269
Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor 267
Comparison of uricase-bound and uricase-loaded erythrocytes as bioreactors for uric acid degradation. 256
Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38 255
Comparison of uricase-bound and uricase-loaded erythrocytes as bioreactors for uric acid degradation 249
Design and characterization of decoy oligonucleotides containing locked nucleic acids 248
The Ubiquitin Gene Expression Pattern and Sensitivity to UBB and UBC Knockdown Differentiate Primary 23132/87 and Metastatic MKN45 Gastric Cancer Cells 246
2',3'- Dideoxycytidine permeation of the human erythrocyte membrane. 244
Binding of non-catalytic ATP to human hexokinase I highlights the structural components for enzyme-membrane association control. 241
Acetaldehyde dehydrogenase-loaded erythrocytes as bioreactors for the removal of blood acetaldehyde 240
Drug delivery systems 240
Efficient inhibition of macrophage TNF-alpha production upon targeted delivery of K48R ubiquitin 236
Human red blood cells as bioreactors for the release of 2', 3'-dideoxycytidine, an inhibitor of HIV infectivity. 229
Identification of blood erythroid markers useful in revealing erythropoietin abuse in athletes 222
Cloning and expression of a new human polypeptide which regulates protein phosphorylation in Escherichia coli 222
Hexokinase 221
Human hexokinase type I microheterogeneity is due to different amino-terminal sequences 220
High-level expression and purification of a human "mini"-hexokinase 220
The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB) 216
Activation of the ubiquitin proteolytic system in murine acquired immunodeficiency syndrome affects IkB-alpha turnover 215
DOWNREGULATION OF NITRIC OXIDE FORMATION BY CYTOSOLIC PHOSPHOLIPASE A2-RELEASED ARACHIDONIC ACID. 215
Red Blood Cell Membrane Processing for Biomedical Applications 214
Overexpression of wild-type ubiquitin downregulates transcription of endogenous polyubiquitin genes in HeLa cells 210
Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity. 207
Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity 203
Genomic DNA in human blastocoele fluid 203
Structural determinants that make hexokinase susceptible to ubiquitin- and ATP-dependent proteolysis 202
A new humanized antibody is effective against pathogenic fungi in vitro 199
ALCUNE PROPRIETÀ DI GLOBULI ROSSI UMANI SOTTOPOSTI A DIALISI IPOTONICA E RISIGILLAMENTO DA UTILIZZARE COME VEICOLI O BIOREATTORI. 196
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides 195
Expression, purification and preliminary crystallographic studies of human hexokinase I 195
Human hexokinase type I microheterogeneity is due to different amino-terminal 194
Normalization of hyperglycemia in diabetic mice by enzyme-loaded erythrocytes 194
Role and mechanism of hexokinase decay during reticulocyte maturation and cell aging 194
Modulation of ICAM-1 expression in ECV304 cells by macrophage-released cytokines 194
In vivo accelerated acetaldehyde metabolism using acetaldehyde dehydrogenase-loaded erythrocytes 193
Monitoring erythropoietin abuse in athletes 192
REVERSED-PHASE LIQUID CHROMATOGRAPHIC DETERMINATION OF 2’, 3’-DIDEOXYCYTIDINE IN HUMAN BLOOD SAMPLES 191
Dynamic changes in immunoproteasome assembly and capping with regulatory particles in an invitro model of senescing macrophages 190
Improved stability of 2,3-bisphosphoglycerate during storage of hexokinase-overloaded erythrocytes 189
In vivo accelerated acetaldehyde metabolism using acetaldehyde dehydrogenase-loaded erythrocytes. 189
Modulation of NF-kB activation by targeted delivery of dexamethasone to macrophages 189
Molecular bases of hexokinase deficiency 187
Drug-loaded red blood cells for the control of the inflammatory response: selective targeting of nuclear factor-kB (NF-kB) 186
Expression of hexokinase mRNA in human hippocampus 185
Improved metabolic properties of hexokinase-overloaded human erythrocytes 183
Hexokinase mutations that produce nonspherocytic hemolytic anemia 182
Patterns of immunoproteasome subunit expression and assembly into proteolytic particles in gastric cancer cells with different histotypes: implications for cancer metastasis 178
Ubiquitin overexpression leads to stabilization of p53 and increased p21 (CIP1/WAF1) transcription by promoting E6AP autodegradation in HeLa cells 176
Enzymatic properties of overexpressed human hexokinase fragments 174
Ubiquitin over-expression promotes E6AP degradation and reactivation of the p53/mdm-2 pathway 172
FKBP12-loaded erythrocytes as a potential delivery system for the immunosuppressant Tacrolimus 169
Localization and age-dependent expression of hexokinase mRNA in the rat brain 167
Human red blood cell loading with hexokinase-inactivating antibodies. An in vitro model for enzyme deficiencies 163
LOCKED NUCLEIC ACIDS (LNA): VERSATILE TOOLS FOR DESIGNING OLIGONUCLEOTIDE DECOYS WITH HIGH STABILITY AND AFFINITY 162
Role of hexokinase in the regulation of erythrocyte hexose monophosphate pathway under oxidative stress 162
Ubiquitin-dependent regulation of E6AP protein levels 161
Design of decoys oligonucleotides stabilized by Locked Nucleic Acids. 160
Engineering new metabolic pathways in isolated cells for the degradation of guanidinoacetic acid and simultaneous production of creatine. 159
Induction of ubiquitin C (UBC) gene transcription is mediated by HSF1: role of proteotoxic and oxidative stress 158
Extraction and reversed-phase high-performance liquid chromatographic determination of 2',3'-dideoxycytidine from human blood samples. 156
Development and in vitro characterization of a humanized scFv against fungal infections 155
Selective inhibition of NF-kB activation and TNF-alpha production in macrophages by red blood cell-mediated delivery of dexamethasone 153
Red blood cell loading with hexokinase and hexokinase-inactivating antibodies. A new strategy for studying the role of enzymes in red cell metabolism and removal 143
Different intron-mediated enhancement mechanisms for the 5'-UTR intron of the human UbC gene 142
UbC trascription is modulated by a mechanism that senses ubiquitin pool dynamics. 142
Overexpression of ubiquitin downregulates transcription of the endogenous UbC gene in HeLa cells 141
Role of heat shock transcription factors in the induction of UbC gene expression in MG132-treated cells 139
Efficient inhibition of macrophage TNF-alpha production by red cell mediated drug targeting 136
Preclinical and clinical developments in enzyme-loaded red blood cells: an update 136
MOLECULAR BASES OF NONSPHEROCYTIC HEMOLYTIC ANEMIA DUE TO HEXOKINASE MUTATIONS 134
Modulation of macrophage activation by red cell-mediated drug targeting 132
Extraction and reversed-phase high-performance liquid chromatographic determinaton of 2',3'-dideoxycytidine from human blood samples. 131
Engineered Red Blood Cells for the delivery and targeting of corticosteroid analogues 126
Dexamethasone effects in Ataxia Telangiectasia cell metabolism. 124
Molecular mechanism involved in glucocorticoid analogue action in Ataxia Telangiectasia: diferrentially expressed genes in AT cell lines in response to Dexamethasone 124
INCREASED GLUCOSE CONSUMPTION BY HUMAN AND MICE ERYTHROCYTES OVERLOADED WITH HEXOKINASE AND GLUCOSE OXIDASE. 121
Transgene-derived wild-type and mutant ubiquitin affects both proteolysis and transcription in HeLa cells. 121
Totale 21.794
Categoria #
all - tutte 78.677
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.677


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022791 0 0 0 152 36 44 49 60 91 71 29 259
2022/20231.688 198 90 28 179 164 341 1 153 311 71 97 55
2023/2024815 51 42 16 78 26 118 22 298 8 69 7 80
2024/20252.062 106 94 420 135 62 116 256 94 227 154 204 194
2025/20264.567 502 372 511 853 487 333 564 118 278 331 156 62
2026/2027987 99 107 466 315 0 0 0 0 0 0 0 0
Totale 22.817